ReviewCancers2022
The Renaissance of Cyclin Dependent Kinase Inhibitors.
Tobias Ettl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
33 papers cite it
this papercites it
ReviewCancers2022
Tobias Ettl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.